Michael R Megna
CHIEF ACCOUNTING OFFICER · 4 filings · Latest: Jul 15, 2026
Kiniksa Pharmaceuticals International, plc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KNSA | Michael R Megna | CHIEF ACCOUNTING OFFICER | Sep 3, 2026 | Sale | $80.30 | 4,600 | $369.4K | 29,062 | |
KNSA | Michael R Megna | CHIEF ACCOUNTING OFFICER | Sep 1, 2026 | Option Exercise | — | 11,496 | — | 39,193 | |
KNSA | Megna Michael R | — | Sep 3, 2026 | Proposed Sale | $80.30 | 4,600 | $369.4K | — | |
KNSA | Michael R Megna | CHIEF ACCOUNTING OFFICER | Apr 9, 2026 | Sale | $46.69 | 6,625 | $309.3K | 27,418 | |
KNSA | Megna Michael R | — | Apr 9, 2026 | Proposed Sale | $46.69 | 6,625 | $309.3K | — | |
KNSA | Michael R Megna | CHIEF ACCOUNTING OFFICER | Apr 7, 2026 | Option Exercise | $1.00 | 3,932 | $3.9K | 35,709 | |
KNSA | Michael R Megna | CHIEF ACCOUNTING OFFICER | Apr 1, 2026 | Option Exercise | — | 7,564 | — | 34,982 | |
KNSA | Megna Michael R | — | Oct 20, 2025 | Proposed Sale | $38.88 | 50,490 | $2.0M | — | |
KNSA | Megna Michael R | — | Sep 3, 2025 | Proposed Sale | $34.84 | 11,000 | $383.2K | — | |
KNSA | Megna Michael R | — | Aug 4, 2025 | Proposed Sale | $32.35 | 17,000 | $549.9K | — | |
KNSA | Megna Michael R | — | Jun 3, 2025 | Proposed Sale | $28.75 | 15,211 | $437.3K | — | |
KNSA | Megna Michael R | — | May 7, 2025 | Proposed Sale | $26.69 | 17,647 | $471.0K | — | |
KNSA | Megna Michael R | — | Mar 12, 2025 | Proposed Sale | $22.45 | 9,051 | $203.2K | — | |
KNSA | Megna Michael R | — | Nov 27, 2024 | Proposed Sale | $22.45 | 17,697 | $397.3K | — |